Hospital @ Home Model of Care for Cirrhosis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorIndiana University

About this trial

The purpose of this study is to work with patients diagnosed with end-stage liver disease to understand their perspectives on the Health at Home (H@H) Program, including desired outcomes and expectations, perceived barriers, and drivers. H@H is an emerging model of home-based care, designed to extend traditional, inpatient hospital care which may address these needs. Through H@H, acute medical care services as well as ancillary care such as rehabilitation therapy can be delivered in the home. The study is divided into three phases: Phase 1 occurs while the participant is an inpatient. Phase 2 is when the actual H@H program takes place as part of the participant's clinical care. The study team will not be involved in the Phase 2 - H@H program as it will be conducted by the clinical staff. Phase 3, at which point the participant enters a rehabilitation phase to transition the patient to self-management, involves a research jam session with the participant and caregiver to assess the value of the program.

Eligibility criteria

Qualifiers

Enrolled into IUH's H@H program

At least 18 years of age

Chronic liver disease/cirrhosis based on characteristic clinical, laboratory, and imaging findings

English speaking

Disqualifiers

Unable to complete study questionnaires due to neurocognitive disease, legal blindness or hearing loss

Transplant of organ other than liver

Pregnant

Incarcerated

Trial design

Treatments tested in this trial

  • Indiana University Health Hospital at Home Program

Treatment groups

30 Participants
are divided into 1 treatment group

Sponsors and collaborators